<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    SCYNEXIS, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About SCYNEXIS, Inc.

    SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $84,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marco Taglietti, M.D.
    • FOUNDED
      1999
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Dova Pharmaceuticals, Inc.

    Dova Pharmaceuticals, Inc.

    Dova is a pharmaceutical company focused on acquiring, developing and commercializ...

    Dova is a pharmaceutical company focused on acq...

    Filing Type:    PU
    Syros Pharmaceuticals, Inc.

    Syros Pharmaceuticals, Inc.

    Syros is redefining the power of small molecules to control the expression of gene...

    Syros is redefining the power of small molecule...

    Filing Type:    PU
    Merus N.V.

    Merus N.V.

    Merus is a clinical-stage immuno-oncology company developing innovative full-lengt...

    Merus is a clinical-stage immuno-oncology compa...

    Filing Type:    PU
    BioSculpture Technology, Inc

    BioSculpture Technology, Inc

    BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device man...

    BioSculpture Technology, Inc. (“BST”) is a ...

    Filing Type:    RA
    Kodiak Sciences Inc

    Kodiak Sciences Inc

    Kodiak Sciences is a clinical stage company developing innovative therapeutics to ...

    Kodiak Sciences is a clinical stage company dev...

    Filing Type:    PU
    Luminex Corporation

    Luminex Corporation

    LuminexÂŽ Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietar...

    LuminexÂŽ Corporation (NASDAQ: LMNX) develops, ...

    Filing Type:    PU
    CytoDyn Inc.

    CytoDyn Inc.

    CytoDyn is a publicly traded late stage biotechnology company developing innovativ...

    CytoDyn is a publicly traded late stage biotech...

    Filing Type:    PU
    argenx SE

    argenx SE

    argenx is a clinical-stage biotechnology company developing a deep pipeline of dif...

    argenx is a clinical-stage biotechnology compan...

    Filing Type:    PU
    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on ...

    Bellicum Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    Spero Therapeutics, Inc.

    Spero Therapeutics, Inc.

    Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical compan...

    Spero Therapeutics, Inc. is a multi-asset, clin...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.